Composition
- Active ingredients
- METHYLDOPA 500MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- METHYLDOPA 250MG · TabletNDA018934-001 · Discontinued
- METHYLDOPA 500MG · TabletNDA018934-002 · Discontinued
- METHYLDOPA 250MG · TabletANDA071752-001 · Discontinued
- METHYLDOPA 500MG · TabletANDA071753-001 · Discontinued
- METHYLDOPA 500MG · TabletANDA070247-001 · Discontinued
- METHYLDOPA 125MG · TabletANDA070331-001 · Discontinued
- METHYLDOPA 500MG · TabletANDA070537-001 · Discontinued
- METHYLDOPA 125MG · TabletANDA071105-001 · Discontinued
- METHYLDOPA 250MG · TabletANDA071106-001 · Discontinued
- METHYLDOPA 250MG · TabletANDA070246-001 · Discontinued
- METHYLDOPA 250MG · TabletANDA070332-001 · Discontinued
- METHYLDOPA 500MG · TabletANDA070670-001 · Discontinued
- METHYLDOPA 125MG · TabletANDA071700-001 · Discontinued
- METHYLDOPA 125MG · TabletANDA072126-001 · Discontinued
- METHYLDOPA 500MG · TabletANDA070452-001 · Discontinued
- METHYLDOPA 250MG · TabletANDA070669-001 · Discontinued
- METHYLDOPA 125MG · TabletANDA070070-003 · Discontinued
- METHYLDOPA 125MG · TabletANDA070073-001 · Discontinued
- METHYLDOPA 250MG · Tablet
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA070262.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Methyldopa
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Watson Labs
- Status
- Discontinued
- Application
- ANDA070262-001